Effective fiscal and administrative management helps provide a solid
foundation for the delivery of clinical services. Alcohol and other drug (AOD)
treatment programs often face shrinking budgets and cutbacks -- despite intense
demands for improvements regarding the qualification of clinicians, quantifiable
treatment outcomes, and the quality of service delivery. This has been a time
of profound change with regard to health care delivery services -- for both
providers and payers in private and public spheres. More change is on the
horizon, such as national health care reform. While such reform seems
inevitable, the specifics are yet to be determined, and the effect on AOD
treatment delivery is as yet unknown. For these reasons, a few aspects of
program administration warrant a brief discussion in this TIP:
Quality improvement
Public funding
Private funding
Managed care
Program costs.
Quality Improvement
Many people in AOD programs are familiar with the terms quality
assessment and quality improvement in relation to meeting Federal and State
regulations, or meeting the standards for accreditation by such organizations as
the Joint Commission on Accreditation of Healthcare Organizations. In the past,
the responsibility and perceived responsibility for quality assessment and
improvement within an AOD treatment program was assigned to an individual who
was designated as the "QA person." While it is true that program administration
and clinical administration have the ultimate authority to establish policy and
modify procedures regarding quality improvement, all program personnel --
clinical and nonclinical -- are responsible for quality improvement efforts at
all program levels.
Indeed, the emphasis on the importance of all employees being an integral
part of quality improvement is part of a sound management approach that puts
significant emphasis on meeting the needs of the customer or client as an
essential aspect of improving the quality of service delivery. One such
management approach is called Total Quality Management (TQM). Although TQM
origins are in the private business sector, it is becoming an integral component
of private and public health services delivery systems. For example, the Joint
Commission on Accreditation of Healthcare Organizations, an organization that
has as its mission the improvement of the quality of health care, is making a
purposeful shift away from describing these efforts as "quality assessment and
improvement," and toward the concept of "improving organizational performance."
By doing so, they are explicitly stressing the continual improvement of
health care service delivery by improving the performance of all staff members,
prompting enhanced performance of the program, and resulting in improved service
delivery (Joint Commission on Accreditation of Healthcare Organizations, 1993).
A Brief Look at TQM
TQM is a focused management philosophy for providing the leadership,
training, and motivation to continuously improve an organization's management
and operations (Walton, 1990). The TQM approach includes
several strategies and assumptions that are easily adaptable to IOT programs.
These strategies include:
Recognition of quality as the presence of value rather than the
mere absence of defect
Focusing on prevention of problems rather than merely eliminating
late-stage problems
Creation of a working environment where all employees seek continuous
improvement
Emphasizing significant cross-training and teamwork
Focusing on the services being delivered as well as the process of
providing services
Forging a provider-customer partnership to work on improvements.
There are several key principles that are intrinsic to TQM. These include a
focus on the customer, continual process improvement, communication, strategic
quality planning, quality leadership, quality skills training, and quality
measures. The heart and soul of TQM are the principles of continued focus on
the customer and continual improvement of the process involved in providing
customer products and services. These key principles can be understood as steps
that form the basis of an ongoing cycle of change and improvement. When one
phase of the cycle is completed, the cycle begins anew.
Customer focus -- Irrespective of funding or setting, AOD
programs provide services to various customers. Thoughtful consideration must
be given to the idea of what constitutes a customer for an AOD treatment
program. Indeed, it is critical to identify all the customers in the system.
While patients are one obvious type of customer, there are others, including
referral sources, family members, employers, funding sources, and other
providers. Central to the TQM approach is a constant emphasis on satisfying the
needs of the customer and identifying ways that can best meet those needs.
Importantly, there should be an understanding of the strengths and weaknesses in
the system from the customer's perspective, and involvement of the customer in
problem solving.
Continuous process improvement -- Service delivery involves
products and processes. Products are the things that are provided to a
client, including treatment services. Processes include everything that
is done to provide the client with the products and services. Programs that are
actively involved with making quality improvements must focus on both products
and processes and continual improvements. The emphasis is on improvement, not
compliance with existing structures. The goal is to reduce chronic waste of
time, labor, material, and funds. Often this involves the identification and
analysis of critical processes and the simplification and removal of variation.
Communication -- The TQM approach recognizes that the individuals
who are actually performing certain jobs are the best sources for identifying
improvement opportunities for those job functions. Thus, to encourage
program-wide participation, all staff, including administrators, must share
information and experiences continually. This can be accomplished through
newsletters, suggestion boxes, teamwork days, meetings, and other events.
Strategic quality planning -- Critical to TQM is having a vision or
mental image of a future state where the quality of service delivery always
elicits satisfaction. A goal is a statement of attainable achievement that can
be proposed and accomplished with sustained effort and energy over a given
length of time. Specific vision statements help program staff to identify the
kind of future that is preferred for the program. Setting quality goals helps
motivate employees and promotes teamwork. In order to achieve quality goals,
programs must be committed and must communicate that commitment to all staff
members. An initial step is to formalize the organizational planning process.
Quality plans include such elements as mission, goals, measurable objectives,
vision, customer identification, quality policies, management principles,
benefits, expectations, external and internal measures, role of quality
assurance, and productivity initiatives. Through employee committees,
documentation, and constant communication, the plan becomes a part of the
day-to-day operations and the culture of the organization.
Quality leadership -- Program leaders (both administrators and
program staff) have critical roles in the development of quality within their
programs. They help provide a focus on the patient. They can support and
encourage all staff to participate in quality improvement and install
structures, such as task forces and steering committees, and allocate resources.
They become role models and nonverbally communicate their commitment to quality
by directing their attention to promotion of quality. As previously mentioned,
employees who perform certain tasks are often the best sources for identifying
improvement opportunities for those tasks. Since such staff members may not
have great stature in the formal hierarchy, it is essential that staff members
become empowered by administrators and management. In this way, anyone can
assume leadership roles within the program.
Quality skills training -- TQM involves a plan for providing
training about quality in order for employees to achieve quality goals and
objectives. Ultimately, all staff should be trained in the tools and techniques
of TQM. Staff training should include such topics as quality principles and
concepts, continuous process involvement, problem solving, setting measurable
objectives (benchmarking), working in teams, managing in a participative
environment, evaluating outcomes, and communications.
Quality measures -- In order to identify opportunities for quality
improvement, programs must assess where their strengths lie. This can be done
through regular assessment processes that check for compliance with Federal or
State laws or accreditation requirements. This can also be accomplished through
patient feedback, questionnaires, focus groups, and other practices. But the
focus of TQM is on the utilization of quality measures. Measures may be
utilized throughout an organization to provide feedback on a regular basis
regarding the degree to which the program is meeting its quality goals,
objectives, and standards. An array of methods may be used to simplify data
collection and statistical analysis and develop useful, reliable information
that serves as a real-world scorecard. These may include client surveys,
benchmarking, statistical process control, work flow analysis, and cost of
quality measures.
These measures are not limited to providing care, but can also be applied
with regard to such problems as waiting lists. From the perspective of TQM,
waiting lists relate to customer satisfaction issues: patient discontent based
on the inaccessibility of treatment services. Thus, TQM would approach the
subject of waiting lists in an ongoing, revolving cycle of improvement, in this
case, continually making improvements that result in shorter waiting lists.
Quality improvement is an essential aspect of IOT programming. TQM
practices can be easily adapted to the IOT program environment and can have a
tremendous impact with regard to improving AOD treatment. TQM projects have
been used in the IOT setting for such purposes as the following:
Analyzing treatment planning and continuity of care issues that
arise in IOT from the widespread use of outside agencies to address a range of
medical, psychiatric, and psychosocial issues of program clients
Examining defined interdisciplinary problems and issues and establishing
problem-solving groups across the different disciplines when integrated services
are delivered within the IOT setting.
Permanent Program Mechanisms for Quality Improvement
All IOT programs should adhere to the following quality improvement
guidelines.
Staff should continually look for opportunities for improvement
within the service delivery area, focusing on defining the breadth of customers
served by the program. While the patient is the most obvious customer, staff
should consider referral sources, funding sources, ancillary care providers,
employers, and family members as customers to whom services are provided.
IOT staff should measure the effectiveness of the IOT program based on such
program variables as the length of client retention, the level of patient
participation, and the frequency and patterns of attendance. Also, they should
monitor patient information, including discharge status and program completion,
patient relapse, and return to treatment.
For some evening IOT programs, involvement in quality improvement efforts
can be challenging regarding the issue of using part-time contract staff as
group therapists. Such staff may be present in the program only during hours
when full-time, permanent staff are not available, creating potential
communication problems between the two groups. One strategy for involving
part-time staff in the quality improvement process is to have them cofacilitate
therapy groups with a member of the full-time core staff and/or establish a
regular channel for communication and feedback, such as regularly scheduled
meetings, phone calls, or written communication logs.
Programs should conduct customer surveys to obtain direct feedback
on program strengths and weaknesses and recommendations for improvement from
clients, referral sources, family members, funding sources, and other programs.
Programs should gather data to help State programs accurately determine
what variables will help predict whether an AOD abuser will stay in IOT care or
will progress therapeutically. For example, programs can compare baseline
assessments of clients who complete treatment with the assessments of clients
who do not complete treatment.
In IOT outcome evaluations, it is important to include all program
participants, including those who have dropped out of treatment. Also, in a
State system, which has many types of treatment programs, cross-program
comparisons can be made when it is impossible to make random assignment.
The examination of administrative issues should not be avoided when IOT
practices are evaluated. There should be adequate resources allocated to
administrative needs, including continuous quality improvement.
Outcome Measures
Evaluation of program outcome is a very effective way of obtaining the
information needed to improve some aspects of the quality of the program. IOT
programs can incorporate outcome evaluations in relation to ongoing clinical
work and patient improvement. IOT programs must establish and clarify program
goals and objectives in order to conduct an outcome analysis, and to know the
meaningful outcome indicators.
Moreover, outcome data should be used not only to determine whether the IOT
program is doing a "good" or "bad" job, but also to interpret the nuances. For
instance, when looking at AOD use among clients, a complete picture of the
overall program impact on the client is needed, including general psychosocial
and quality-of-life indicators. A considerable amount of data can be examined
without sophisticated statistical analysis. For instance, IOT programs should
be able to examine program attendance and patient outcome data and be able to
readily apply findings to the program evaluation processes. An appropriate
management information system should be implemented to ensure rapid and complete
access to outcome data.
A variety of outcome measures are needed, including staff and administrative
measures, special population measures, general treatment population measures,
and treatment services.
Staff and administrative measures. Staff and administrative
measures clarify outcomes by holding staff responsible for particular program
components and by making them active participants in the ongoing processes of
the program. Using program evaluations, staff turnover rates should be examined
in different IOT programs as a measure of the level of staff satisfaction.
However, when making a decision regarding program philosophy, caution should be
used regarding how the staffing satisfaction data are used. Occasionally,
program changes that foster superior client care can precipitate initial
discomfort and resistance among program staff.
Special population measures. It is important to emphasize that
program and patient outcome indicators will be different for different treatment
groups. For instance, clients with dual disorders may have a different
threshold for attendance than AOD patients without dual disorders. Additional
outcomes that are meaningful with this group include medication compliance,
psychiatric symptom improvement, and rehospitalization. Similarly, special
outcome indicators may be appropriate for pregnant IOT clients including
delivery complications and birth outcomes for infants.
General treatment population measures. A useful outcome measurement
tool is the Addiction Severity Index (ASI) (McLellan et al.,
1980; 1985; 1992a). The ASI
can be administered at IOT intake and discharge by trained assessment staff
members. Used at intake, it leads logically to treatment planning. At
discharge, it yields specific outcome data in seven key areas of the client's
life, including recent AOD use and legal, occupational, medical, family/social,
and psychiatric status.
The ASI provides IOT programs with:
A subjective patient evaluation and an interviewer evaluation of
problem severity, both of which can provide an indication of patient treatment
priorities.
An easy monitoring tool for clinical supervision since severity scores in
each domain can be quickly checked to ensure adequate treatment planning in
problem areas.
The capability to monitor outcomes of discharged clients through community
followup. (Patients can be located and reevaluated using the ASI followup
interview.)
A research tool structured to derive objective and subjective measures of
need and improvement.
A rich database by which such issues as the relationship between client
characteristics and outcome data can be examined.
A standardized assessment instrument that permits comparisons across
programs and levels of care.
Treatment Services Review. The Treatment Services Review was
developed to complement the ASI and corresponds directly to ASI categories (McLellan et al., 1992). This instrument provides a structured way of
measuring patient perception of the quantity of services received in each of the
seven ASI areas. That is, it yields a perceived services-delivered rating.
Other important measures of patient-level service delivery include: number of
individual counseling sessions, number of group counseling sessions, number of
urine tests and Breathalyzer checks, and length of stay.
Other measures. IOT programs also should conduct client
satisfaction surveys as an evaluation tool. Self-help group involvement is
another way of measuring continued sobriety and determination to retain or
regain any short-term loss of sobriety.
One measure of particular relevance to the IOT setting is the successful
transfer and retention of clients in long-term standard outpatient services
following completion of the IOT program. Patient follow-through with the
transition plan should be automatic. A primary goal of IOT services should be
to motivate clients to remain in ongoing recovery programs.
External Evaluation Processes
A number of institutionalized review processes provide useful feedback for
IOT programs, including:
Accreditation organizations -- Often, State accreditation
processes, such as licensing or certification divisions, as well as national
accreditation bodies, such as the Joint Commission on Accreditation of
Healthcare Organizations, or the Commission on Accreditation of Rehabilitation
Facilities, provide a readily available, and often mandated, source of quality
improvement.
Consultants -- IOT administrators may find it helpful to seek
professional assistance in defining and clarifying their program mission.
Consultants can be particularly helpful with respect to program development,
preparing mission statements, stating program philosophies, and translating all
of these into procedural policy. Consultants can not only help programs
establish and plan TQM programs, they can also "sell" the importance of the TQM
process to staff members by conducting staff presentations on TQM.
Governing board -- Whether by choice or because of State
regulations, many IOT programs have advisory and/or governing bodies that
oversee the development and operations of the program. Members of such
governing bodies should have familiarity with AOD treatment and should have
ample time to be actively involved. Governing board members should see their
role as working in a complementary relationship with the program staff with the
common goal of overall success of the program.
A clear mission statement helps make the program direction explicit and
realistic. It also helps decrease the tendency of programs to overextend
themselves by offering services or treating client populations that are outside
their intended mission.
Therapeutic Setting
The appearance of the facility sends a powerful message to IOT clients about
dignity and respect. The appearance of the facility can have an impact on
patients' assessment of program quality. IOT programs should consider the
following recommendations:
Plan ahead for flexibility regarding treatment team and group
space. Maximize the flexibility of available space. When designing a new
facility, first evolve an understanding of space needs in order to custom-design
the space for most efficient use.
Keep furniture and facility resources in good working order. The physical
surroundings should be clean and tidy.
Design a space for clients to get away from the therapy rooms during breaks
in treatment. Clients need a physical break from the intensive sessions. Space
itself can be therapeutic.
Many IOT programs will want to provide refreshments, and a dining room or
cafeteria area is ideal. At the least, a snack machine and coffee should be
available.
For some treatment groups, particularly large urban programs serving a
homeless population, shower and laundry facilities will make the IOT program
more attractive.
Certain literature and didactic information should be available. Updated
self-help meeting schedules should be present in high-traffic areas such as the
clinic lobby.
Bathrooms should be conveniently located near group therapy rooms and
recreational space. Also, the bathrooms should be designed with the need for
collection of urine samples for drug screening in mind. Alternatives include
one-way mirrors, space for direct observation, and the ability to temporarily
turn off the water supply.
Whenever possible, IOT programs -- especially those with extended hours --
should have a recreation room for patients. These areas should be designed to
promote client socialization.
Each IOT program has to thoughtfully address its smoking policy. This is
both a facility and a program philosophy issue. If smoking is allowed
internally, make sure the rights of nonsmokers are protected.
A centralized entrance for client registration may be useful, depending on
the particular client groups and setting. This has the added benefit of
monitoring who is coming in and out of the program.
The neighborhood setting is important. While programs should be located in
the areas where the target patients reside, the program also should be in a safe
location, and be secure. Patients and staff should feel safe participating in
treatment, especially in evening programs. Consideration should be given to the
level of acceptance that the neighborhood has for the program. Efforts should
be made to ensure as cooperative and supportive arrangements as possible.
Public Funding
For most States, the amounts of fiscal support from general revenue and
Federal block grants have been inadequate to finance the level of services
demanded by the public. Major grant funds, for example, have been used to
provide treatment to high-risk youth, women and children, and intravenous drug
users. Fortunately, block grant requirements do not restrict the eligibility of
any particular types or models of programs. Hence, AOD treatment programs that
are based on the intensive outpatient treatment (IOT) level of care are eligible
for block grant funds.
Since the States have a fair amount of discretion about the use of block
grant funds, they often seek programs that will make effective use of existing
monies. One such strategy is to identify specific groups for which State money
can be targeted and for which IOT programs can be created. For example, IOT
programs may be created to treat such specific groups as intravenous drug users,
adolescents, clients with dual disorders, incarcerated offenders, and women and
their infants and children. Targeting services to these groups may also help
States meet certain Federal block grant requirements, such as the current
requirements to give treatment preference to pregnant drug users.
Unfortunately, however, when IOT programs are designed to provide care for
narrowly targeted groups, their ability to provide care for the general
population of addicted people may be restricted. This means they will be unable
to treat many people who require the type of treatment provided by IOT programs.
Thus, program planners need to balance these concerns, utilize creative
strategies, and identify strategies and additional sources of funding that will
permit the broadening of services.
Alternative sources of public funding are available to establish and
maintain IOT programs. These sources include funds allocated by Federal or
State programs in criminal justice, AIDS, maternal and child health, and mental
health and demonstration and set-aside funds from the Center for Substance Abuse
Treatment (CSAT) and the Center for Substance Abuse Prevention (CSAP). For
example, CSAT, CSAP, the National Institute on Alcohol Abuse and Alcoholism, and
the National Institute on Drug Abuse have supported demonstration projects
targeting several specific groups, such as the homeless, pregnant women, and
women of childbearing age. These projects, awarded competitively, offer
excellent opportunities for innovative programming with an emphasis on a
comprehensive continuum of services.
The amount of State funds available to support AOD abuse treatment programs
varies widely among the States. Program managers and staff should aggressively
seek out and identify potential sources of State funds, and improve the skills
required to write and submit grant applications. IOT programs are in especially
good positions to develop creative alliances with other treatment providers and
submit joint grant applications when permissible.
At this time, Medicaid is an important funding source for providing AOD
treatment based in IOT programs. IOT program administrators should be fully
informed about State regulations governing the use of Medicaid funds. Some
States, for example, may attempt to ensure equitable distribution by granting
programs specific amounts of Medicaid and State-match funds. Some programs may
not use their full allocation, and the balance can be used by other programs
that need more funds. This requires administrators to have a full understanding
of the State's procedures and regulations for Medicaid granting and matching.
In some cases, where experience has shown that certain programs are able to
attract more Medicaid clients than others, the State will arrange for them to
bill beyond the amount of their individual grant, as long as the State's pool of
Medicaid funds is not exhausted.
In some situations, Medicaid will pay half the cost for treating individuals
under age 17. A major problem with Medicaid is that many States do not provide
Medicaid coverage for males who are not chronically ill or elderly. At intake
it is important to ask men if they have custody of children. If they do, they
are probably eligible for Medicaid coverage themselves.
Another creative alternative is a partnership between health maintenance
organizations (HMOs) and managed care businesses to provide IOT coverage. A
special program can be developed so that patients served by these plans can
receive targeted treatment services that conform to their benefits.
In some instances, counties have developed their own managed care programs
or even created their own IOT programs -- such as adolescent IOT programs --
which are funded entirely with county taxes. Programs may be able to draw on
local, county, or township taxes. This approach saves the jurisdiction from
having to pay out-of-county treatment providers for inpatient care. Similarly,
some very large employers have developed their own IOT programs for AOD problems
among employees.
In many cases, IOT services can be added to existing residential treatment
programs. However, there is a risk that allocating funds for an IOT level of
care may actually diminish the available funds for the residential treatment
program. Sometimes, when the inpatient facility is reimbursed on a
fee-for-service basis, the outpatient programs may be misused as a feeder to the
inpatient program.
However, IOT can be combined with residential care in the same program to
maximize the opportunity for patient-placement matching, enhance the continuum
of care, and reduce the overall cost of AOD treatment services. Some clients
require a period of residential stabilization before they can successfully take
part in IOT. If admitted directly to IOT, they may relapse. The duration of
residential care needed can vary greatly from patient to patient, and must be
tailored to individual patients' rates of improvement. However, the goal should
be to transition clients to the least restrictive level of care as soon as
possible.
The development of State regulations defining and governing IOT programs is
a critical step in the recognition and reimbursement of individual programs. As
States develop a licensure or regulatory category for this level of care, IOT
programs can more easily receive reimbursement.
Private Funding
Benefit structures are underdeveloped in relation to the reimbursement of
IOT by private payers. While reimbursement strategies have been developed for
inpatient AOD abuse treatment, many third-party payers have not developed any or
adequate reimbursement strategies for the IOT level of care.
It is critical for programs that provide or intend to provide IOT services
to establish an ongoing dialogue with major payers. Indeed, this dialogue
should begin prior to opening an IOT program. This will diminish or possibly
eliminate surprises and problems related to reimbursement and clinical issues.
Specifically, third-party payers should be given the opportunity to provide
input into the development of reimbursement strategies and should be invited to
join with the program as partners in providing quality intensive outpatient
treatment.
To enhance cooperation with payers, IOT program providers should pursue and
obtain the accreditation, licensing, and certifications that the payers
recommend or require. Certifications cannot usually be obtained before a
program is operational. These may include Joint Commission on Accreditation of
Healthcare Organizations, Commission on Accreditation of Rehabilitation
Facilities, and State accreditation.
Suggestions for Providers
Providers should create and maintain a database related to
services that the various payers will reimburse. This database should include:
payers (insurer's name, phone number, address, contact people) and information
regarding deductibles, copayments, daily rates, capitation (maximum payments),
and billing procedures. A tracking mechanism should be included to specify
recertification requirements when they exist.
Providers should meet in person with the reviewers and decisionmakers who
approve admissions. By so doing, the provider and payer can have a clear
understanding of each other's expectations, practices, and policies. For
example, there should be a clear understanding regarding what constitutes a
treatment day and how nontreatment days are to be considered.
Providers should obtain written copies of payers' policies and guidelines
for billing and payment, and not rely solely on phone conversations.
In situations where payers will not furnish providers with written policies
and procedures, the provider should send a confirming followup letter or fax
memorandum that summarizes the content of a conversation or phone call. Written
documentation of informal understandings and agreements can save much money,
time, and frustration.
Payers are increasingly requiring outcome data for reimbursable treatment
services. Thus, providers should collect outcome data, so that they can
demonstrate quality treatment and quality improvement. Often such data can be
gathered at little or no cost by using graduate students or trained support
staff to collect followup client information.
Providers should inform payers that research suggests that for some
patients, IOT provides a level of care equivalent to inpatient treatment. This
is not true for nonintensive outpatient treatment (Fink et
al., 1985). Therefore, careful patient-treatment matching is needed to
ensure that clients are placed in the least restrictive and most cost-effective
type of treatment program, based on the severity of their presenting AOD use
problem, medical and psychiatric status, and psychosocial conditions. Providers
should provide payers with admission criteria that distinguish IOT patients from
patients that can be served by lower intensity outpatient services. Further,
IOT programs should ensure that the level of care offered is clearly distinct
from that available in nonintensive outpatient programs?
Providers should inform payers that IOT has an important place in
continuing care, since the longer clients remain in outpatient treatment, the
higher is the likelihood of a more stable recovery (McCaul and
Svikis, 1991).
When communicating with payers, providers should clearly and carefully
describe the specific types, intensity, range, and levels of IOT services that
are provided to help payers make informed and educated decisions.
Providers should establish assertive, close, and ongoing linkages to social
service organizations and health care programs that offer other types and levels
of care with the greatest cost effectiveness, if services are not provided
inhouse.
During the intake phase of IOT treatment, it is useful to identify whether
the client may have additional reimbursement coverage through a spouse's or
other family member's insurance policy. Sometimes, despite a client's own
exhausted benefits, coverage may be obtained through a secondary payer.
Some payers may regard IOT as an add-on or optional service. It is the
responsibility of IOT treatment providers to educate payers that IOT is a
specific level of care that can provide a level of treatment intensity that
approaches medically monitored inpatient treatment but is achieved in an
outpatient setting. Importantly, payers should understand that IOT is a vital
part of the continuum of care that includes: 1) medically managed inpatient
treatment, 2) medically monitored inpatient treatment, 3) intensive outpatient
treatment, and 4) outpatient treatment. Payers should also be educated that IOT
is a level of care, not a specific type or model of program. For example,
payers should be taught that IOT can be adapted to several models such as day
treatment, evening treatment, weekend treatment, partial hospitalization, and
treatment in combination with housing such as apartments, dormitories, or other
forms of resident housing.
Providers and payers should understand that moving clients from one level of
care to a less intense level of care (such as from inpatient care to IOT) will
utilize the continuum of care, decrease daily treatment costs, and make it
possible to provide prolonged episodes of treatment. However, it is imperative
for providers to remind payers that the decisions to move clients from one level
of care to another should always be based on the individual client's treatment
needs.
In some cases, where payers do not yet have a policy regarding insurance
policy conversion from inpatient to outpatient treatment, they may not be able
to guarantee this service. However, individual insurance company staff may be
able to informally provide such a conversion. In any case, informed agreements
should be in writing to avoid misunderstandings that may occur later. There is
an increased likelihood for such flexibility when effective, proactive, and
ongoing communication and collaboration exists between providers and payers.
There is a need for IOT programs to collaborate with one another in lobbying
efforts. Organized National, State, and local institutions can help educate
legislators, as well as payers, regarding the benefits of IOT and demonstrate
their support for particular payer reimbursement strategies. Professionals from
employee assistance programs can work with benefits departments to explain the
utility of IOT programs
Managed Care
It is clear that the process of reforming America's health care delivery
system is under way. However, it is less clear what the final health care
reform package will look like. Also, it is unknown how the new system will
affect AOD treatment, mental health services, and Medicaid. In fact, once
negotiations are complete and new laws have been established, it is likely that
new health care reform policies will be phased in over several years. It is
likely that several years will pass before the ultimate effects on AOD treatment
and mental health are thoroughly understood. Understandably, and often because
of poor experiences with some managed care companies, AOD treatment program
administrators are apprehensive about the potential negative effects of a
national health care system that incorporates managed care and managed
competition.
In existing managed care programs, problems may arise regarding the
patient's right to confidentiality in seeking AOD treatment. In managed care
settings, patients typically seek initial help from an employee assistance
program professional or their managed care provider physician or case worker who
then makes the appropriate recommendations and referrals. However, managed care
provider physician records are not protected under the Federal confidentiality
regulations governing AOD treatment programs. Thus, managed care provider
physician records are subject to more liberal disclosure. As a consequence,
patient information is not strictly protected in the same way as records in AOD
treatment programs.
Clients may not want the managed care provider to reveal to anyone else that
they have an AOD abuse problem. Authorization for AOD treatment would require
clients to disclose their AOD status to their managed care provider. This is an
issue that some States are beginning to address and regulate.
Under managed care models, a capitated agreement -- or at-risk contract --
may be an integral component of providing care. This capitated agreement
involves the payment of a monthly or annual flat fee to a treatment provider who
agrees to provide a specified range of services to all clients covered by the
contract who seek treatment. In effect, to be ensured of regular payments, the
provider accepts the risk for delivery of services. In such agreements, the
provider should be particularly careful to determine utilization rate histories
for the particular geographic areas being served. These rates vary greatly and
can have a dramatic impact on costs. For example, utilization rates can range
from one to six patients per 1,000 population seeking treatment -- a sixfold
range!
Providers that choose to become involved with capitated agreements should
request and obtain a utilization rate history. In other words, the provider
should have an understanding of the number of people or the percentage of the
program's base group that are expected to seek care each year. Similarly, the
provider should carefully consider the implications associated with taking the
risk for all AOD treatment needs -- which may include detoxification, and
inpatient and outpatient treatment -- compared with a capitated agreement that
requires only the delivery of IOT and outpatient treatment.
Although the cost of managing care for IOT is less expensive to develop and
operate than the cost for many other conditions, it is not inexpensive. Indeed,
comprehensive AOD treatment involves attending to medical, psychiatric, and AOD
problems that require sophisticated clinical interventions. These interventions
require the use of licensed, credentialed, and certified professionals.
Program Costs
Very little data exist on IOT program costs. Although less expensive to
operate than inpatient treatment, good IOT programs are not generally
inexpensive. Also, they have more difficulty than inpatient programs in
generating significant profit margins even when efficiently organized and
managed.
The consensus panel obtained data on total expenses and total revenues from
six different day or evening IOT treatment programs, in the northeast, Midwest,
and southern part of the Nation in rural, urban, and suburban areas. The
programs have various payer mixes, including insurance, managed care, Medicaid,
Medicare, HMO contract, State grant or purchase of care, and self-pay. Also
represented were private nonprofit and for-profit programs as well as a public
program, with a variety of client capacities and salary ranges. These data are
provided in Exhibit 6-1.